Relapsing Multiple Sclerosis
1 competing product in clinical development for Relapsing Multiple Sclerosis.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Placebo + Pirtobrutinib | Eli Lilly | Phase 2 | Withdrawn | 52 |
1 competing product in clinical development for Relapsing Multiple Sclerosis.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Placebo + Pirtobrutinib | Eli Lilly | Phase 2 | Withdrawn | 52 |